Cadila Healthcare Limited has informed the Exchange regarding a press release dated September 02, 2020, titled "Zydus Cadila receives final approval from the USFDA for Cisatracurium Besylate Injection".
Press Release Sep 02 2020
Filed with NSE · · 2 pages · English
Release
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
Later from Zydus Lifesciences
- Press Release Sep 03 2020
- Press Release Sep 09 2020
- Press Release Sep 11 2020
- Press Release Sep 18 2020
- Press Release Sep 24 2020
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences